1. Using antibodies against P2Y and P2X receptors in purinergic signaling research
- Author
-
Melanie R. Grably, Alon Meir, Dovrat Brass, Ofra Gohar, and Noemi Bronstein-Sitton
- Subjects
P2Y receptor ,Purinoceptors ,medicine.diagnostic_test ,P2Y receptors ,Purinergic signaling ,P2X receptors ,Purinergic receptor ,Cell Biology ,Purinergic signalling ,Biology ,Antibodies ,Cell biology ,Cellular and Molecular Neuroscience ,Western blot ,G protein-coupled receptors ,Ion channels ,medicine ,Original Article ,Signal transduction ,Receptor ,Neuroscience ,Molecular Biology ,Ionotropic effect ,G protein-coupled receptor - Abstract
The broad expression pattern of the G protein-coupled P2Y receptors has demonstrated that these receptors are fundamental determinants in many physiological responses, including neuromodulation, vasodilation, inflammation, and cell migration. P2Y receptors couple either G(q) or G(i) upon activation, thereby activating different signaling pathways. Ionotropic ATP (P2X) receptors bind extracellular nucleotides, a signal which is transduced within the P2X protein complex into a cation channel opening, which usually leads to intracellular calcium concentration elevation. As such, this family of proteins initiates or shapes several cellular processes including synaptic transmission, gene expression, proliferation, migration, and apoptosis. The ever-growing range of applications for antibodies in the last 30 years attests to their major role in medicine and biological research. Antibodies have been used as therapeutic tools in cancer and inflammatory diseases, as diagnostic reagents (flow cytometry, ELISA, and immunohistochemistry, to name a few applications), and in widespread use in biological research, including Western blot, immunoprecipitation, and ELISPOT. In this article, we will showcase several of the advances that scientists around the world have achieved using the line of antibodies developed at Alomone Labs for P2Y and P2X receptors.
- Full Text
- View/download PDF